Patients with ST-elevation myocardial infarction ( STEMI ) preferentially received prasugrel , while those with non-STEMI , a history of stroke or transient ischaemic attack , age 75years , or weight < 60kg received clopidogrel or reduced dose of prasugrel to comply with the prasugrel label .